Depression and Anxiety Trial, Recruiting NCT05810259 Sponsor: Yale University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT05810259
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who currently live in the United States.

Who may not be able to join:

  • People who report chest pain, discomfort or pressure in the chest, difficulty breathing or shortness of breath, dizziness, fainting, or blackouts.
  • People with high blood pressure, where the top number is above 140 or the bottom number is above 90.
  • People who have been diagnosed with or treated for heart disease, heart murmur, chest pain (angina), irregular heartbeat, or a heart attack.
  • People who have had heart surgery, angioplasty, a pacemaker, a valve replacement, or a heart transplant.
  • People with a resting heart rate above 100 beats per minute.
  • People who have arthritis, back trouble, hip, knee, or joint pain, or any other bone or joint condition.
  • People whose doctor has advised them not to do light to moderate physical exercise for any medical or physical reason.
  • People whose doctor has recommended against light to moderate physical exercise due to asthma, diabetes, epilepsy, high cholesterol, or a hernia.
  • People whose answers to a depression screening questionnaire score above a certain level (confirm with trial site for exact score details).
  • People whose answers to a panic disorder screening questionnaire score above a certain level (confirm with trial site for exact score details).
  • People whose answers to a generalised anxiety screening questionnaire score above a certain level (confirm with trial site for exact score details).
  • People whose answers to a psychosis screening questionnaire score above a certain level (confirm with trial site for exact score details).
  • People whose answers to a mania screening questionnaire score above a certain level (confirm with trial site for exact score details).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: David Klemanski, Psy.D., MPH, Yale University

Phone: 203.214.5426

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
22 May 2024
Est. completion
1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Mindfulness assessed by the Five Facet Mindfulness Questionnaire (FFMQ); Change in Exercise Behavior assessed by the Behavior Regulation Exercise Questionnaire, Third Version (BREQ-3); Utility of the Modules assessed by self report; Daily stressors assessed using the Brief Daily Stressors Screening Tool (BDSST); Average number of minutes spent on Intervention; Change in health behavior motivation assessed using the Health Behavior Motivation Scale (HBMS); CHange in health behavior assessed using he Health Behavior Inventory-20 (HBI-20).; Quality of life assessed using the Quality of...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov